ironjustice

Hypertension can be caused by too many red blood cells.
Reduction of red blood cells controls this .. hypertension .. caused
by erythrocytosis .. increased red blood cells.

"therapeutic effect of phlebotomy in posttransplant hypertension
associated with erythrocytosis."

------------------------------------------------------------------------------

http://tinyurl.com/2r5uqs

Hypertension: Uncontrolled and Taking Over the World

LONDON, UK -- August 16, 2007 -- The biggest problem for controlling
hypertension (high blood pressure) is compliance with treatment, says
an Editorial in this week's Cardiology Special Edition of The Lancet.

The Editorial, which ties in with a Seminar on hypertension, says:
"Despite very effective and cost-effective treatments, target blood
pressure levels are very rarely reached, even in countries where cost
of medication is not an issue. Many patients still believe that
hypertension is a disease that can be cured, and stop or reduce
medication when blood pressure levels fall."

The risk of becoming hypertensive for a person in a developed country
exceeds a "staggering" 90%, and the increasingly common combination
and interaction of hypertension with obesity, diabetes and
hyperlipidaemia, if left untreated for too long, leads to
cardiovascular disease, stroke, renal failure and death.

The disease burden of hypertension is expected to massively increase
in the coming years. In 2000, the estimated number of adults living
with high blood pressure was 972 million; this is expected to increase
to 1·56 billion by 2025. The Editorial says: "Lifestyle factors, such
as physical inactivity, a salt-rich diet with high processed and fatty
foods, and alcohol and tobacco use, are at the heart of this increased
disease burden, which is spreading at an alarming rate from developed
countries to emerging economies, such as India and China."

The Editorial concludes: "Physicians need to convey the message that
hypertension is the first, and easily measurable, irreversible sign
that many organs in the body are under attack. Perhaps this message
will make people think more carefully about the consequences of an
unhealthy lifestyle and give preventative measures a real chance."

The Seminar, authored by Dr. Franz Messerli, Division of Cardiology,
St Luke's-Roosevelt Hospital Center, Columbia University, New York and
colleagues, takes a detailed look at hypertension, its underlying
causes and associated risk factors. The authors state that neither
beta-blockers nor thiazide diuretics should be used as first line
therapy in uncomplicated hypertension.

They conclude: "Most hypertensive patients need two or more drugs for
blood-pressure control and concomitant statin treatment for risk
factor reduction. Despite the availability of effective and safe
antihypertensive drugs, hypertension and its concomitant risk factors
remain uncontrolled in most patients."


SOURCE: The Lancet

-----------------------------------------------------------------------------------------------------

Clin Nephrol. 1993 Oct;40(4):241-3. Related Articles, Links


Therapeutic efficiency of phlebotomy in posttransplant hypertension
associated with erythrocytosis.


Barenbrock M, Spieker C, Rahn KH, Zidek W.


Medizinische Poliklinik, Westfalischen Wilhelms-Universitat, Munster,
Germany.


Hypertension is a major complication in kidney transplantation and
contributes to the high cardiovascular mortality of renal
transplanted
recipients. The aim of the present study was to evaluate the
therapeutic effect of phlebotomy on blood pressure in posttransplant
hypertension associated with erythrocytosis. In 12 renal transplanted
patients (7 male, 5 female, aged 29-52 years) with erythrocytosis
(defined by hematocrit > 52% or hemoglobin > 170 g/l), a
24-hour-monitoring of blood-pressure and heart rate (SpaceLabs
SL90207)
was performed before, 2 and 6 weeks after phlebotomy. Patients with
iron-deficiency and/or transplant rejection were excluded from the
study. Ten of 12 patients were on antihypertensive treatment before
phlebotomy. Phlebotomy (500 ml) was repeated three times on average
within the first two weeks, until hematocrit decreased below 45%. The
phlebotomy therapy lowered the hematocrit after two weeks from 54.8
+/-
2.8% to 44.3 +/- 4.2% and 43.0 +/- 5.6% after six weeks. Before
phlebotomy, the blood pressure was systolic 153.2 +/- 15.1 mmHg and
diastolic 95.2 +/- 9.5 mmHg. After repeated phlebotomy, there was a
significant decrease of blood pressure to systolic 139.0 +/- 14.1 and
diastolic 85.3 +/- 8.2 mmHg (p < 0.01). Without change of hematocrit
and hemoglobin, there was no further change of blood pressure after
six
weeks (systolic 140.1 +/- 9.9 mmHg, diastolic 86.3 +/- 9.5 mmHg). The
heart rate did not change significantly during the therapy. The
antihypertensive treatment could be reduced in most of the patients.
The present study demonstrates the therapeutic effect of phlebotomy
in
posttransplant hypertension associated with erythrocytosis.(ABSTRACT
TRUNCATED AT 250 WORDS)


Publication Types:
Clinical Trial


PMID: 8261683 [PubMed - indexed for MEDLINE]


---------------------------------------------------------------------------*-----


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk